Englander Institute for Precision Medicine

Publications

Found 690 results
Author Title Type [ Year(Asc)]
2022
Li C, Klingler S, Bodo S, Cheng J, Pan Y, Adileh M, Martin MLaura, Fuller J, Feldman R, Michel A et al..  2022.  Acid Sphingomyelinase-Ceramide Induced Vascular Injury Determines Colorectal Cancer Stem Cell Fate.. Cell Physiol Biochem. 56(4):436-448.
Jaiswal A, Verma A, Dannenfelser R, Melssen M, Tirosh I, Izar B, Kim T-G, Nirschl CJ, K Devi SP, Olson WC et al..  2022.  An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes.. Cancer Cell. 40(5):524-544.e5.
Ambler W, Santambrogio L, Lu TT.  2022.  Advances in understanding and examining lymphatic function: relevance for understanding autoimmunity.. Curr Opin Rheumatol. 34(2):133-138.
Martini R, Delpe P, Chu TR, Arora K, Lord B, Verma A, Bedi D, Karanam B, Elhussin I, Chen Y et al..  2022.  African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.. Cancer Discov. 12(11):2530-2551.
Orlando F, Romanel A, Trujillo B, Sigouros M, Wetterskog D, Quaini O, Leone G, Xiang JZ, Wingate A, Tagawa S et al..  2022.  Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay.. NAR Cancer. 4(2):zcac016.
Ciani Y, Fedrizzi T, Prandi D, Lorenzin F, Locallo A, Gasperini P, Franceschini GMarco, Benelli M, Elemento O, Fava LL et al..  2022.  Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer.. Cell Syst. 13(2):183-193.e7.
Doane AS, Elemento O.  2022.  Alterations in transcriptional networks in cancer: the role of noncoding somatic driver mutations.. Curr Opin Genet Dev. 75:101919.
Huffman BM, Aushev VN, Budde GL, Chao J, Dayyani F, Hanna D, Botta GP, Catenacci DVT, Maron SB, Krinshpun S et al..  2022.  Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers.. JCO Precis Oncol. 6:e2200420.
Meggendorfer M, Jobanputra V, Wrzeszczynski KO, Roepman P, de Bruijn E, Cuppen E, Buttner R, Caldas C, Grimmond S, Mullighan CG et al..  2022.  Analytical demands to use whole-genome sequencing in precision oncology.. Semin Cancer Biol. 84:16-22.
Stenzl A, Sternberg CN, Ghith J, Serfass L, Schijvenaars BJA, Sboner A.  2022.  Application of artificial intelligence to overcome clinical information overload in urological cancer.. BJU Int. 130(3):291-300.
Brendel M, Su C, Bai Z, Zhang H, Elemento O, Wang F.  2022.  Application of Deep Learning on Single-cell RNA Sequencing Data Analysis: A Review.. Genomics Proteomics Bioinformatics. 20(5):814-835.
Elkhader J, Elemento O.  2022.  Artificial intelligence in oncology: From bench to clinic.. Semin Cancer Biol. 84:113-128.
Fucikova J, Hensler M, Kasikova L, Lanickova T, Pasulka J, Rakova J, Drozenova J, Fredriksen T, Hraska M, Hrnciarova T et al..  2022.  An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors.. Clin Cancer Res. 28(14):3053-3065.
Yamazaki T, Galluzzi L.  2022.  BAX and BAK dynamics control mitochondrial DNA release during apoptosis.. Cell Death Differ. 29(6):1296-1298.
Kasi PMurtaza.  2022.  Call for Adoption of Synchronized Biweekly Dosing of Anti-EGFR Agent Cetuximab: Implications for Patients with Metastatic Colorectal Cancer, and Squamous Cell Carcinoma of the Head and Neck.. Oncologist. 27(5):336-337.
Galluzzi L, Kroemer G.  2022.  Calreticulin surface presentation can promote quality control of hematopoietic stem cells.. Trends Immunol. 43(12):950-952.
Sternberg CN, Shin N, Chernyshov K, Calabrò F, Cerbone L, Procopio G, Miheecheva N, Sagaradze G, Zaichikova A, Samarina N et al..  2022.  Case report: Metastatic urothelial cancer with an exceptional response to immunotherapy and comprehensive understanding of the tumor and the tumor microenvironment.. Front Oncol. 12:1006017.
Manic G, Galluzzi L, Vitale I.  2022.  Catastrophic DNA replication in unscheduled tetraploid cells.. Trends Genet. 38(8):787-788.
Napoli S, Cascione L, Rinaldi A, Spriano F, Guidetti F, Zhang F, Cacciapuoti MTeresa, Mensah AAdjeiwaa, Sartori G, Munz N et al..  2022.  Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma.. Haematologica. 107(5):1131-1143.
Kulm S, Kolin DA, Langhans MT, Kaidi AC, Elemento O, Bostrom MP, Shen TS.  2022.  Characterization of Genetic Risk of End-Stage Knee Osteoarthritis Treated with Total Knee Arthroplasty: A Genome-Wide Association Study.. J Bone Joint Surg Am. 104(20):1814-1820.
Tang F, Xu D, Wang S, Wong CKhuan, Martinez-Fundichely A, Lee CJ, Cohen S, Park J, Hill CE, Eng K et al..  2022.  Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets.. Science. 376(6596):eabe1505.